Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).
about
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosisThe clinical relevance of autoantibodies in sclerodermaCurrent perspectives on the immunopathogenesis of systemic sclerosisAssociation between the HLA-DRB1 gene and clinical features of systemic sclerosis in KoreaHLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicineAssociation of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.Comparing HLA shared epitopes in French Caucasian patients with scleroderma.Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donorsEvaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic SclerosisHLA markers for poor prognosis in systemic sclerosis Brazilian patients.Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort.Deciphering the genetic background of systemic sclerosis.Toxicological effects of trichloroethylene exposure on immune disorders.The role of the trimolecular complex (alpha beta TCR-MHC+peptide) in the pathogenesis of systemic sclerosis.HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes.Is occupational organic solvent exposure a risk factor for scleroderma?Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture.Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.Angiotensin II Type 1 receptor (AGTR1) gene polymorphisms are associated with vascular manifestations in patients with systemic sclerosis (SSc).
P2860
Q24597261-14550E88-9DD3-4A71-BF10-C88EF513D0B1Q24645988-2AA69749-7C61-434F-8B47-9B71E9AFED0AQ24682842-FA2C6B07-672B-4BC3-99DD-D3863690DF2CQ26741264-74C42F0E-498F-41C8-BC8E-50B6F0D4329AQ28296258-ABD72175-9CB7-4137-A220-FBF5EF24EA54Q33855367-AA9C9150-AF98-43E2-B497-C89A05AAE42EQ33855883-AA0D0F98-1BA2-49ED-A9C9-4CF7B28D6FAAQ33945954-9123F693-0935-47A5-A9B4-34AADFDE5C6CQ33955502-7821D3F6-AD07-405E-A3CF-5F2E4663CF7AQ34046875-18F50CA7-A099-4D51-A5FD-25C62FC7A580Q34081935-061786DF-7F07-4CF4-AA44-6F821BF5D1F9Q34216833-A02C39D5-698C-48C0-BA4C-77C7FEDD54DCQ34277474-A4FBB6F8-F38D-4886-BC3C-A7EEB1CD5E8DQ34498250-12FF3684-A2D7-4E3C-A29B-8073488856DCQ35549272-7763A72A-BC8B-4FDD-88F1-E20FA13A805CQ35629254-7B9E663A-60F3-4F2F-8AC8-7B7FE08CAD09Q35637820-7CB7ED5D-E76E-42A2-9375-1AF2C902D8F4Q35751372-9D5431E3-C29B-4033-8C68-B1CD04AFDFDDQ36063970-5A678620-828F-4CA8-B0BE-719A1D544905Q37176585-AA0427A5-6447-4826-BD47-A9F90115C862Q37455235-E45352EF-EF38-4BA9-98BF-69764950DD46Q37905783-CA04276F-D0A7-4329-A73E-482B9D9709EDQ38638908-17E7AF24-FA9C-4076-AC63-DE5BCE91A7F3Q40468561-995C0B04-B60D-4537-AF2B-A8575ACA5D84Q41471335-9C6BD2D3-3189-4D62-8AE0-CD134208361BQ41826432-8A960454-09B4-4E61-B874-5F5E2F7E0E4CQ42541669-D523F568-E178-44DA-B218-19676462089CQ43989009-7220C027-EFDC-4BB1-B181-B277FA97692EQ46187058-7FB6CED1-0641-4F39-B8C5-11089ADCB7BCQ46463646-4ECD47C9-FE5B-494F-ADCA-89DDC088A8EBQ51476905-B944E76F-A561-4D4E-A1F6-71F237CBD4A9
P2860
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Association of amino acid sequ ...... ogressive systemic sclerosis).
@ast
Association of amino acid sequ ...... ogressive systemic sclerosis).
@en
type
label
Association of amino acid sequ ...... ogressive systemic sclerosis).
@ast
Association of amino acid sequ ...... ogressive systemic sclerosis).
@en
prefLabel
Association of amino acid sequ ...... ogressive systemic sclerosis).
@ast
Association of amino acid sequ ...... ogressive systemic sclerosis).
@en
P2093
P2860
P356
P1476
Association of amino acid sequ ...... ogressive systemic sclerosis).
@en
P2093
F C Arnett
M J MacLeod-St Clair
R D Altman
R Goldstein
P2860
P304
P356
10.1172/JCI115974
P407
P577
1992-09-01T00:00:00Z